<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <p content-type="self-citation">
  <mixed-citation publication-type="self-citation" id="bph15164-cit-0001">
   <string-name>
    <surname>Sousa</surname>
    <given-names>LP</given-names>
   </string-name>, 
   <string-name>
    <surname>Pinho</surname>
    <given-names>V</given-names>
   </string-name>, 
   <string-name>
    <surname>Teixeira</surname>
    <given-names>MM</given-names>
   </string-name>. 
   <article-title>Harnessing resolving‐based therapeutics to treat pulmonary viral infections: What can the future offer to COVID‐19?</article-title>. 
   <source xml:lang="en">Br J Pharmacol</source>. 
   <year>2020</year>
   <pub-id pub-id-type="doi">10.1111/bph.15164</pub-id>
  </mixed-citation>
 </p>
 <fn-group id="bph15164-ntgp-0001">
  <fn id="bph15164-note-0001">
   <p>This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/bph.15164.</p>
  </fn>
 </fn-group>
</notes>
